Abstract Title:

Chemo-surveillance: a novel concept of the natural defence mechanism against cancer.

Abstract Source:

Drugs Exp Clin Res. 1987 ;13 Suppl 1:71-6. PMID: 3569019

Abstract Author(s):

M C Liau, M Szopa, B Burzynski, S R Burzynski

Abstract:

Synthetic Antineoplaston A10, 3-phenylacetylamino-2,6-piperidinedione, has been shown to produce promising clinical results, similar to those obtained with antineoplastons derived from urine. Antineoplaston A10 is capable of reducing the excessive excretion of peptides often associated with cancer patients, thereby boosting endogenous levels of antineoplaston. Its therapeutic effect is partially attributable to endogenous antineoplastons, the level of which Antineoplaston A10 can help to raise. A patient must have a certain reserve of endogenous antineoplastons in order to benefit from therapy with Antineoplaston A10. The critical plasma peptide level seems to be above 30 nmoles/ml. Patients who responded favourably to the treatment with Antineoplaston A10 invariably showed an increase of plasma peptide levels and a decrease of urinary excretion of peptides. These results suggest that the body, under normal circumstances, is protected by antineoplastons against cancer. This chemical mechanism of protection is hereby termed chemo-surveillance.

Study Type : Review
Additional Links

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.